Treatment with the demethylation agent 5-azacytidine (5-AzaC) restored expression of IGF1 in two of EP-like gastric cancer cells (MKN28 and SNU16, Supplementary Fig. 17). The gene discussed is IGF1; the disease is gastric cancer.